Epstein Secrets

eptember 30, 2015. Martin Albers was appointed to the Supervisory Board effective October 1, 2015 through a decision taken by the District Court of Essen on October 2, 2015 in accordance with Section 104 of the German Stock Corporation Act (AktG). Glinter Adam resigned from the Supervisory Board effec

he strategic management and ongoing development of the legal entities. fi This introduced the principle of differentiated management. Consequently, the Nutrition & Care and Resource Efficiency segments now have an even stronger focus on growth, while the Performance Materials segment is run as a financing business.

dustries AG is an international specialty chemicals company headquartered in Germany. Its registered office is at Rellinghauser Strafte 1-11, 45128 Essen (Germany), and the company is registered in the Commercial Register at Essen District Court under HR8 No.19474. The present consolidated financial

ew applications and enter new markets. In principle, these opportunities and risks may affect all segments, but they are particularly relevant for the Nutrition & Care and Per- formance Materials segments. One potential risk factor for our amino acids business, for example in Asia, is the possible impact of substa

position of the Group, together with a description of the material opportunities and risks associated with the expected development of the Group. Essen, February 19, 2016 Evonik Industries AG The Executive Board Dr. Engel Dr. Kaufmann Kullmann Wessel Wolf EFTA00598843 TOOUR SHAREHOLDERS MA

e Board a) NATIONAL-BANK AG b) Borussia Dortmund Geschaftsfahrungs-GmbH Dr. Ralph Sven Kaufmann, Dusseldorf (since July 1, 2015) Responsible for the Nutrition & Care, Resource Efficiency and Performance Materials segments a) Evonik Nutrition & Care GmbH (since July 1, Juli 2015*, Chair since September 14, 2015)